September 15, 2026-September 16, 2026 C-Path’s 2026 Global Impact Conference C-Path's flagship event is set to return to downtown Washington, D.C. this September 15-16 at the...
September 15, 2026 C-Path’s Translational Therapeutics Accelerator Awards $1.7 Million Across Five BRIDGe Grants in Brain Health, Pediatrics and Rare Disease Five research teams advance small molecule, protein-based and gene therapy candidates for conditions where existing options fall s
September 4, 2026 Building the Foundation for Future PKD Breakthroughs: CDISC, PKD Foundation, and Critical Path Institute Expand Global Research Standard, New PKD Data Standard Aims to Multiply the Impact of Research Investments Worldwide The Clinical Data Interchange Standards Consortium (CDISC), in partnership with the PKD Foundation and Critical Path Institute...
September 3, 2026 C-Path Mourns the Passing of Board Member Peter Barton Hutt TUCSON, Ariz., September 3, 2026 — Critical Path Institute® (C-Path) is deeply saddened to announce the passing of Peter...
September 3, 2026 Advancing Neuromuscular Drug Development Through Patient-Centered Collaboration and Data Integration The newest episode of the Critical Path Institute Podcast explores the essential collaboration between patients...
August 27, 2026 From One to Millions: Julia Vitarello on a New Vision for Individualized Medicine "I'm very, very determined to play a role together with everyone at C-Path and others to try to make sure that the millions of...
August 25, 2026 Critical Path for Parkinson’s Announces Milestone Publication Highlighting FDA Support for Novel Biomarker to Advance Precision Medicine Strategies TUCSON, Ariz., August 25, 2026 — Critical Path Institute® (C-Path) today announced the publication of "Regulatory...
August 24, 2026 Building a Stronger Path to Therapies for Hereditary Spastic Paraplegia and Primary Lateral Sclerosis For more than 20 years, the Spastic Paraplegia Foundation (SPF) has worked toward a future with better...
August 24, 2026 Successful Translational Prediction of Bedaquiline’s Phase 2a Clinical Trial Results against Tuberculosis: The Zebrafish as a New Approach Methodology Tuberculosis remains an urgent global health crisis that requires an accelerated development of novel regimens.
August 20, 2026 C-Path Achieves Internationally Recognized Certification for Information Security Management C-Path) today announced it has achieved certification to ISO/IEC 27001:2022, the internationally...
